Company Announcement no. 11/2020 To: NASDAQ Copenhagen A/S                                           Copenhagen, Denmark, 24 January 2020 Notice to Convene Extraordinary General Meeting Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of Veloxis Pharmaceuticals A/S, CVR no.

Company Release no. 10/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen Following company release no.

Selskabsmeddelelse nr. 10/2020 Til: NASDAQ Copenhagen A/S                                                  København, Danmark, fredag den 24. januar 2020   Offentliggørelse af Anmodning om Afnotering af Veloxis Pharmaceuticals A/S' Aktier fra Nasdaq Copenhagen A/S   Med henvisning til

Company Release no. 9/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S Pursuant to Sections 70-72 of the Danish Companies Act, Asahi Kasei

Selskabsmeddelelse nr. 9/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020   Meddelelse om Tvangsindløsning til Aktionærerne i Veloxis Pharmaceuticals A/S   Asahi Kasei Pharma Denmark A/S har fremsendt meddelelse om tvangsindløsning til aktionærerne i Veloxis

Company Release no. 8/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Friday 24 January 2020 Veloxis Pharmaceuticals A/S: Major Shareholder Notifications Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") hereby announces that it has received

Selskabsmeddelelse nr. 8/2020 Til: NASDAQ Copenhagen A/S København, Danmark, fredag den 24. januar 2020   Veloxis Pharmaceuticals A/S: Offentliggørelse af Storaktionærmeddelelser   Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") offentliggør hermed selskabets modtagelse af

Company Release no. 7/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, Thursday 23 January 2020 Veloxis Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer On 17

Selskabsmeddelelse nr. 7/2020 Til: NASDAQ Copenhagen A/S                                                  København, Danmark, torsdag den 23. januar 2020   Veloxis Forhøjer Aktiekapitalen i forbindelse med Asahi Kasei Pharma Denmarks Udnyttelse af Warrants Erhvervet under det Offentlige Købstilbud

Company Release no. 6/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 17 January 2020 Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer Asahi Kasei Pharma Denmark A/S, which on 15 January 2020 announced

Selskabsmeddelelse nr. 6/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 17. januar 2020   Asahi Kasei Pharma Denmark A/S meddeler det endelige resultat det frivillige offentlige købstilbud   Asahi Kasei Pharma Denmark A/S, som den 15. januar 2020 offentliggjorde det foreløbige resultat af det

Company Release no. 5/2020 To: NASDAQ Copenhagen A/S                                     Copenhagen, Denmark, 15 January 2020   Veloxis Pharmaceuticals: Reporting of Managers' and Closely Associated Persons' Transactions in Veloxis-Shares and Financial Instruments Linked Hereto   Today, Veloxis

Selskabsmeddelelse nr. 5/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Offentliggørelse af ledende medarbejderes og personer, der er nært knyttet til ledende medarbejderes transaktioner med Veloxis-aktier og finansielle instrumenter forbundet hermed

Company Release no. 4/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 15 January 2020 Veloxis Pharmaceuticals: Major Shareholder Notifications Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") hereby announces that it has received major

Selskabsmeddelelse nr. 4/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Offentliggørelse af storaktionærmeddelelser   Veloxis Pharmaceuticals A/S (OMX: VELO) ("Veloxis") offentliggør hermed selskabets modtagelse af storaktionærmeddelelser i henhold

Company Release no. 3/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 15 January 2020 Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark Announces the Preliminary Result and Completion of its Public Tender Offer for the Shares and Warrants in

Selskabsmeddelelse nr. 3/2020 Til: NASDAQ Copenhagen A/S København, Danmark, 15. januar 2020   Veloxis Pharmaceuticals: Asahi Kasei Pharma Denmark offentliggør det foreløbige resultat af samt afslutningen på dets offentlige købstilbud på aktier og warrants i Veloxis Pharmaceuticals   Asahi Kasei

Company Release no. 2/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 12 January 2020 Veloxis Pharmaceuticals:  Reminder of Approaching Deadline for the Acceptance of the Public Tender Offer by Asahi Kasei Pharma Denmark Please refer to the

Company Release no. 1/2020 To: NASDAQ Copenhagen A/S                                                 Copenhagen, Denmark, 09 January 2020 Veloxis Pharmaceuticals: Competition approvals obtained for the public tender offer by Asahi Kasei Pharma Denmark for the shares and warrants in Veloxis